Phase III study of intravenous immunglobulin (IVIG) in patients with heart failure after myocardial infarction.

Trial Profile

Phase III study of intravenous immunglobulin (IVIG) in patients with heart failure after myocardial infarction.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Jan 2014

At a glance

  • Drugs Immunoglobulins
  • Indications Heart failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 30 Jul 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 28 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top